21 related articles for article (PubMed ID: 36017860)
1. Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression.
Pan R; Wang R; Cheng F; Wang L; Cui Z; She J; Yang X
Reprod Biol Endocrinol; 2024 Apr; 22(1):41. PubMed ID: 38605340
[TBL] [Abstract][Full Text] [Related]
2. Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer
Kieszkowski P; Dąbruś D; Grabarek BO; Boroń D
Curr Pharm Biotechnol; 2020; 21(11):1119-1128. PubMed ID: 32297576
[TBL] [Abstract][Full Text] [Related]
3. An optical study of drug resistance detection in endometrial cancer cells by dynamic and quantitative phase imaging.
Yao T; Cao R; Xiao W; Pan F; Li X
J Biophotonics; 2019 Jul; 12(7):e201800443. PubMed ID: 30767401
[TBL] [Abstract][Full Text] [Related]
4. KLF9‑regulated FBXO31 inhibits the progression of endometrial cancer and enhances the sensitivity of endometrial cancer cells to cisplatin.
Yang M; Niu C
Exp Ther Med; 2024 Feb; 27(2):54. PubMed ID: 38234628
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
Wu J; Zhang L; Li H; Wu S; Liu Z
Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
[TBL] [Abstract][Full Text] [Related]
6. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
[TBL] [Abstract][Full Text] [Related]
7. ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.
Bao L; Wu J; Dodson M; Rojo de la Vega EM; Ning Y; Zhang Z; Yao M; Zhang DD; Xu C; Yi X
Mol Carcinog; 2017 Jun; 56(6):1543-1553. PubMed ID: 28112439
[TBL] [Abstract][Full Text] [Related]
8. [Overexpression of leukemia inhibitory factor enhances chemotherapy tolerance of endometrial cancer cells
Ruan X; Zhong M; Liu W; Liu Q; Lu W; Zheng Y; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):20-26. PubMed ID: 32376564
[TBL] [Abstract][Full Text] [Related]
9. Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling.
Zhuang Q; Huang Y; Hong Y; Zhuang W; Zhu K; Huang Z
J Investig Med; 2022 Aug; 70(6):1358-1364. PubMed ID: 35580917
[TBL] [Abstract][Full Text] [Related]
10. T-Box Transcription Factor 2 Enhances Chemoresistance of Endometrial Cancer by Mediating NRF2 Expression.
Ding N; Zhang T; Yu X; Zhuang S
Curr Protein Pept Sci; 2022; 23(8):563-570. PubMed ID: 36017860
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.
Mirzaei S; Mohammadi AT; Gholami MH; Hashemi F; Zarrabi A; Zabolian A; Hushmandi K; Makvandi P; Samec M; Liskova A; Kubatka P; Nabavi N; Aref AR; Ashrafizadeh M; Khan H; Najafi M
Pharmacol Res; 2021 May; 167():105575. PubMed ID: 33771701
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
